Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-11

FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

This FDA document indicates approval of a supplemental application for Somatuline Depot (lanreotide acetate) by Ipsen Biopharmaceuticals, Inc. to support the co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOMATULINE DEPOT (LANREOTIDE ACETATE)

Snippet

SUPPL AP for SOMATULINE DEPOT (LANREOTIDE ACETATE)